VATIS UPDATE Article

The Department of Biotechnology (DBT), under the Ministry of Science and Technology, government of India, Centre for Cellular and Molecular Platforms (C-Camp), Bengaluru, and Aqsens Health Pvt Ltd, Finland, have collaborated with a team in Finland and local partners in Bengaluru to launch a long-term project to validate and bring to the market saliva-based oral cancer screening method developed by Aqsens.

Stating that this is the first international innovative start-up at C-Camp, a press note issued here read: “The parties have collaborated in this area for a couple of years, and with this announced cooperation they will reinforce their joint commitment on remote health monitoring in India,” said C-Camp, adding that the advent of Aqsens on its campus, it has opened its doors to International companies.

Stating that oral cancer is a huge disease burden for India needing interventions for management and prevention, C-Camp said that remote health monitoring is becoming an increasingly important area for national healthcare. Having a cost-efficient and mobile method to screen and monitor diseases like oral cancer will have a significant impact both on the humanity level but also socio-economically, which is what this collaboration aims to achieve.